AngioDynamics raises sales outlook to $313M for FY26 as Med Tech segment accelerates
Source: SeekingAlpha
2025-10-02 10:03:22 ET
More on AngioDynamics
- AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript
- AngioDynamics, Inc. 2026 Q1 - Results - Earnings Call Presentation
- AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul
- AngioDynamics projects $305M–$310M FY26 sales as Med Tech drives double-digit growth
- AngioDynamics Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $80.16M beats by $5.9M
Read the full article on Seeking Alpha
For further details see:
AngioDynamics raises sales outlook to $313M for FY26 as Med Tech segment accelerates
AngioDynamics Inc.
NASDAQ: ANGO
ANGO Trading
-0.05% G/L:
$10.945 Last:
84,906 Volume:
$11 Open:
ANGO Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 23, 2026 04:30:00 pm
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 08:30:00 am
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
February 05, 2026 08:00:00 am
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
ANGO Stock Data
$455,039,941
38,744,343
2.99%
58
N/A
Medical Equipment & Supplies
Healthcare
US
Latham
